Redsense Medical AB (publ) (XSAT:REDS)
Sweden · Delayed Price · Currency is SEK 5.10
+0.20 (4.08%)
At close: Sep 26, 2025
Redsense Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 29.4 | 28.77 | 25.52 | 16.75 | 16.34 | 17.1 | Upgrade |
Other Revenue | - | - | - | 0 | - | - | Upgrade |
| 29.4 | 28.77 | 25.52 | 16.75 | 16.34 | 17.1 | Upgrade | |
Revenue Growth (YoY) | 20.06% | 12.74% | 52.32% | 2.51% | -4.43% | 20.19% | Upgrade |
Cost of Revenue | 11.94 | 10.69 | 12.36 | 5.49 | 5.95 | 7.14 | Upgrade |
Gross Profit | 17.46 | 18.08 | 13.16 | 11.27 | 10.4 | 9.96 | Upgrade |
Selling, General & Admin | 17.44 | 19.76 | 17.54 | 22.46 | 22.77 | 16.6 | Upgrade |
Other Operating Expenses | 2.68 | -1.96 | 0.59 | -1.04 | -0.56 | 1.25 | Upgrade |
Operating Expenses | 20.19 | 17.87 | 18.2 | 21.47 | 22.39 | 18.08 | Upgrade |
Operating Income | -2.73 | 0.21 | -5.04 | -10.21 | -11.99 | -8.12 | Upgrade |
Interest Expense | -0.04 | -0.04 | -0.03 | -0.1 | -0.05 | -0.04 | Upgrade |
Interest & Investment Income | 0.15 | 0.17 | 0.06 | 1.02 | 1.05 | 0.16 | Upgrade |
Earnings From Equity Investments | - | - | - | - | -0.3 | - | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | 2.5 | - | - | Upgrade |
Other Non Operating Income (Expenses) | -0 | - | - | -0 | 0 | - | Upgrade |
EBT Excluding Unusual Items | -2.63 | 0.34 | -5.01 | -6.79 | -11.29 | -8.01 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 0.5 | -1.97 | 3.32 | -1.03 | Upgrade |
Pretax Income | -2.63 | 0.34 | -4.51 | -8.76 | -7.97 | -9.03 | Upgrade |
Net Income | -2.63 | 0.34 | -4.51 | -8.76 | -7.97 | -9.03 | Upgrade |
Net Income to Common | -2.63 | 0.34 | -4.51 | -8.76 | -7.97 | -9.03 | Upgrade |
Shares Outstanding (Basic) | 16 | 17 | 14 | 14 | 14 | 14 | Upgrade |
Shares Outstanding (Diluted) | 16 | 17 | 14 | 14 | 14 | 14 | Upgrade |
Shares Change (YoY) | 11.38% | 21.25% | -0.16% | 0.60% | - | 15.33% | Upgrade |
EPS (Basic) | -0.16 | 0.02 | -0.32 | -0.62 | -0.57 | -0.64 | Upgrade |
EPS (Diluted) | -0.16 | 0.02 | -0.32 | -0.62 | -0.57 | -0.64 | Upgrade |
Free Cash Flow | -0.28 | -8.25 | -5.1 | -9.83 | -12.58 | -6.64 | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.48 | -0.36 | -0.70 | -0.90 | -0.47 | Upgrade |
Dividend Per Share | - | - | - | - | - | 2.140 | Upgrade |
Gross Margin | 59.38% | 62.83% | 51.56% | 67.24% | 63.63% | 58.22% | Upgrade |
Operating Margin | -9.30% | 0.73% | -19.74% | -60.93% | -73.37% | -47.50% | Upgrade |
Profit Margin | -8.93% | 1.19% | -17.69% | -52.27% | -48.78% | -52.83% | Upgrade |
Free Cash Flow Margin | -0.95% | -28.66% | -20.00% | -58.68% | -76.98% | -38.85% | Upgrade |
EBITDA | -2.67 | 0.28 | -4.98 | -10.16 | -11.97 | -8.09 | Upgrade |
EBITDA Margin | -9.08% | 0.96% | -19.50% | -60.61% | -73.21% | -47.33% | Upgrade |
D&A For EBITDA | 0.07 | 0.07 | 0.06 | 0.05 | 0.03 | 0.03 | Upgrade |
EBIT | -2.73 | 0.21 | -5.04 | -10.21 | -11.99 | -8.12 | Upgrade |
EBIT Margin | -9.30% | 0.73% | -19.74% | -60.93% | -73.37% | -47.50% | Upgrade |
Revenue as Reported | 31.12 | 32.63 | 25.56 | 17.79 | 16.9 | 17.15 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.